Artificial Intelligence collaboration identifies existing drugs that could treat sight loss
Initial results from the artificial intelligence collaboration – Action Against AMD – has uncovered a number of existing drugs that have the potential to reduce sight loss from age-related macular degeneration.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>